Escuela de Ciencias de La Salud, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia.
Intensive Care Unit, Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana, Medellín, Colombia.
Crit Care. 2022 May 9;26(1):130. doi: 10.1186/s13054-022-04006-z.
The detection of coinfections is important to initiate appropriate antimicrobial therapy. Molecular diagnostic testing identifies pathogens at a greater rate than conventional microbiology. We assessed both bacterial coinfections identified via culture or the BioFire® FilmArray® Pneumonia Panel (FA-PNEU) in patients infected with SARS-CoV-2 in the ICU and the concordance between these techniques.
This was a prospective study of patients with SARS-CoV-2 who were hospitalized for no more than 48 h and on mechanical ventilation for no longer than 24 h in 8 ICUs in Medellín, Colombia. We studied mini-bronchoalveolar lavage or endotracheal aspirate samples processed via conventional culture and the FA-PNEU. Coinfection was defined as the identification of a respiratory pathogen using the FA-PNEU or cultures. Serum samples of leukocytes, C-reactive protein, and procalcitonin were taken on the first day of intubation. We analyzed the empirical antibiotics and the changes in antibiotic management according to the results of the FA-PNEUM and cultures.
Of 110 patients whose samples underwent both methods, FA-PNEU- and culture-positive samples comprised 24.54% versus 17.27%, respectively. Eighteen samples were positive in both techniques, 82 were negative, 1 was culture-positive with a negative FA-PNEU result, and 9 were FA-PNEU-positive with negative culture. The two bacteria most frequently detected by the FA-PNEU were Staphylococcus aureus (37.5%) and Streptococcus agalactiae (20%), and those detected by culture were Staphylococcus aureus (34.78%) and Klebsiella pneumoniae (26.08%). The overall concordance was 90.1%, and when stratified by microorganism, it was between 92.7 and 100%. The positive predictive value (PPV) was between 50 and 100% and were lower for Enterobacter cloacae and Staphylococcus aureus. The negative predictive value (NPV) was high (between 99.1 and 100%); MecA/C/MREJ had a specificity of 94.55% and an NPV of 100%. The inflammatory response tests showed no significant differences between patients whose samples were positive and negative for both techniques. Sixty-one patients (55.45%) received at least one dose of empirical antibiotics.
The overall concordance was 90.1%, and it was between 92.7% and 100% when stratified by microorganisms. The positive predictive value was between 50 and 100%, with a very high NPV.
检测合并感染对于启动适当的抗菌治疗非常重要。分子诊断检测比传统微生物学更能提高病原体的检出率。我们评估了在哥伦比亚麦德林的 8 家 ICU 中感染 SARS-CoV-2 的患者通过培养或生物梅里埃 FilmArray 肺炎检测试剂盒(FA-PNEU)鉴定的细菌合并感染情况,以及这两种技术之间的一致性。
这是一项前瞻性研究,纳入了在哥伦比亚麦德林的 8 家 ICU 中住院时间不超过 48 小时且接受机械通气时间不超过 24 小时的 SARS-CoV-2 感染患者。我们研究了迷你支气管肺泡灌洗或气管内抽吸样本,这些样本通过传统培养和 FA-PNEU 进行处理。合并感染定义为使用 FA-PNEU 或培养鉴定出呼吸道病原体。在插管的第一天采集白细胞、C 反应蛋白和降钙素原的血清样本。我们根据 FA-PNEU 和培养的结果分析了经验性抗生素治疗和抗生素管理的变化。
在接受了这两种方法检测的 110 例患者样本中,FA-PNEU 阳性和培养阳性的样本分别占 24.54%和 17.27%。两种技术均阳性的样本有 18 例,均阴性的样本有 82 例,1 例培养阳性而 FA-PNEU 阴性,9 例 FA-PNEU 阳性而培养阴性。FA-PNEU 最常检测到的两种细菌是金黄色葡萄球菌(37.5%)和无乳链球菌(20%),而培养最常检测到的两种细菌是金黄色葡萄球菌(34.78%)和肺炎克雷伯菌(26.08%)。总体一致性为 90.1%,按微生物分层时为 92.7%至 100%。阳性预测值(PPV)在 50%至 100%之间,肠杆菌科和金黄色葡萄球菌的 PPV 较低。阴性预测值(NPV)较高(99.1%至 100%);MecA/C/MREJ 的特异性为 94.55%,NPV 为 100%。炎症反应检测结果显示,两种技术均阳性和均阴性的患者之间无显著差异。61 例患者(55.45%)至少接受了一剂经验性抗生素治疗。
总体一致性为 90.1%,按微生物分层时为 92.7%至 100%。阳性预测值在 50%至 100%之间,NPV 非常高。